Rosacea-support - rosacea-support.org - Rosacea Support Group
General Information:
Latest News:
Mirvaso Ingredients 27 Aug 2013 | 09:18 am
The just approved Mirvaso is a milestone in the long development and approval process. Rosacea sufferers have watched this drug since as early as 2004 when patents started emerging. Now that Mirvaso ...
Mirvaso – Frequently Asked Questions 27 Aug 2013 | 06:42 am
Surprise news today that Mirvaso, the product formerly known as Sansrosa, CD07805/47 and Col-118 has been granted approval by the FDA. Here are some of the things we already know about Mirvaso ; The...
Mirvaso Approved for Rosacea Redness 26 Aug 2013 | 06:52 pm
News today that Galderma has succeeded in gaining FDA Approval for Mirvaso – the brand name chosen for the product that during development was known as Sansrosa, CD07805/47 and Col-118. The Brimonidi...
Step backwards for Generic Oracea. Invalid patents are back 9 Aug 2013 | 04:00 am
For those following the saga of the possible availability of Generic Oracea in the future, another twist today. Two of the patents that were previously ruled invalid and thus unable to protect Galderm...
Patent: Combining Sansrosa and Finacea 2 Aug 2013 | 04:00 am
Galderma is staking out its claim on potential rosacea topicals with another patent being published. This patent details potential topicals that are combinations of the active ingredients in Sansrosa ...
Generic Oracea one step closer, Lupin gets Tentative FDA Approval 1 Aug 2013 | 04:00 am
News today that Lupin has been granted tentative approval by the FDA to product a generic version of Oracea. We learn in 2010 that Lupin had filed an abbreviated new drug application to make generic ...
Bionect improves Rosacea Symptoms 18 Jul 2013 | 04:00 am
A recent paper in the Journal of Drugs in Dermatology suggests that Bionect may be helpful for the symptoms of rosacea. The study found that after 4 weeks the burning or stinging and dryness of rosac...
Sansrosa looks to be marketed as Mirvaso 16 Jul 2013 | 08:40 am
Thanks to a post from Barbara, we have learnt that a member of a German support forum for rosacea, that Galderma may be planning to market Sansrosa as Mirvaso. It is pretty brief but here is what we ...
SIG990 Gains IND Status for Rosacea Redness and Lesions 10 Jul 2013 | 04:00 am
Previously known as Signum Biosciences, Signum Dermalogix has announced today that the FDA has granted them IND Status for the Isoprenylcysteine Analog known as SIG990. Investigational New Drug statu...
Promiseb now available as Scalp Wash 3 Jul 2013 | 04:00 am
The nonsteroidal prescription Promiseb is now available as a Scalp Wash. Available only as part of `Promiseb Complete’, Promiseb Plus Scalp Wash is said to have “earned favorable ratings from patient...
